Prelude Therapeutics, Inc. PRLD
NASDAQ · United States · Health Technology
$3.67-0.12 (-3.17%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.14 | -0.20 | +28.8% | $5.70M | — | +18.6%$4.83→$5.73 |
| Q1 2026 | 2026-05-12 | -0.13 | -0.27 | +51.9% | — | — | -2.9%$4.80→$4.66 |
| Q4 2025 | 2026-03-10 | -0.20 | -0.18 | -11.1% | — | — | +23.3%$3.09→$3.81 |
| Q3 2025 | 2025-11-12 | -0.26 | -0.35 | +25.7% | — | — | +11.9%$1.35→$1.51 |
| Q2 2025 | 2025-08-14 | -0.41 | -0.43 | +4.7% | — | — | — |
| Q4 2024 | 2025-03-10 | -0.37 | -0.46 | +19.6% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.46 | -0.43 | -7.0% | — | — | — |
| Q4 2023 | 2024-02-15 | -0.45 | -0.49 | +8.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.